According to the results of a newly published study conducted in Utah, cannabis has the potential to to serve as an alternative to opioids for chronic pain management.
For the study, published on Utah.gov, researchers analyzed the impact of medical cannabis on opioid prescription rates, focusing on 186 patients with chronic pain diagnoses. The study utilized patient data from Dragonfly Wellness dispensaries and electronic health records, revealing a compelling trend of reduced opioid use following cannabis initiation.
The study found that 84.4% of participants experienced a decrease in their opioid prescriptions after beginning cannabis treatment. On average, opioid consumption, measured in Morphine Milligram Equivalents (MME) per month, dropped by 53.1%. This equated to a reduction from 3,832 MME/month before cannabis use to 1,798 MME/month afterward. Patients using cannabis products with a THC:CBD ratio of 1:0 showed the most significant reductions.
Chronic musculoskeletal pain was the most common condition among participants, and this group demonstrated notable decreases in opioid use. Cannabis consumption via vapes, gummies, and tinctures appeared most effective for reducing opioid reliance.
The study also uncovered that tobacco smokers experienced an increase in opioid prescriptions despite cannabis use, suggesting smoking status may influence treatment outcomes.
The study adds to growing evidence that cannabis could play a pivotal role in addressing the opioid crisis, particularly for chronic pain patients seeking safer, less addictive alternatives.
The study concludes:
The preliminary results from this analysis in patients from Utah support our previous findings on Minnesota, suggesting that cannabis has a substantial role to play in pain management and the reduction of opioid use. As the medical community continues to seek safer pain management options, cannabis may become a key component of treatment strategies, particularly for chronic pain patients. These findings support the hypothesis that cannabis can significantly reduce opioid use among chronic pain patients. This is crucial as it provides a potential pathway to tackle opioid dependency, offering a less addictive alternative for chronic pain management with fewer side effects.
Our results showed that smoking tobacco was associated with an increase in opioid prescriptions. Studies have shown that smoking can exacerbate chronic pain conditions and potentially affect the metabolism of both cannabis and opioids. Non-smokers may experience different therapeutic outcomes compared to current or former smokers when using cannabis for pain management. Additionally, smoking status has been associated with varying levels of compliance and responsiveness to medical treatments, including cannabis.
